Baricitinib for systemic lupus erythematosus
暂无分享，去创建一个
[1] I. Bruce,et al. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial , 2018, The Lancet.
[2] Asher Mullard. FDA approves Eli Lilly's baricitinib , 2018, Nature Reviews Drug Discovery.
[3] Asher Mullard. mRNA vaccines get another booster , 2018, Nature Reviews Drug Discovery.
[4] Massimo Gadina,et al. The JAK-STAT pathway: impact on human disease and therapeutic intervention. , 2015, Annual review of medicine.
[5] Steven M Holland,et al. JAKs and STATs in immunity, immunodeficiency, and cancer. , 2013, The New England journal of medicine.